Hadassah

Cutting-Edge Hadassah Receives Most Advanced Radiotherapy System to Treat Cancer

Thursday, Mar 24 2016

The linear accelerator at the Hadassah Medical Center's Radiotherapy Unit in the Sharett Institute of Oncology.

“The arrival of our new linear accelerator takes us to a whole new level of delivering radiotherapy,” relates Dr. Marc Vigoda, head of the Hadassah Medical Center’s Radiotherapy Unit in the Sharett Institute of Oncology.

Speed and precision are essential parameters in delivering radiotherapy, explains Dr. Vigoda. The challenge is that healthy cells often get destroyed in the process. With this new state-of-the-art accelerator, radiotherapists can deliver higher doses of radiation in less time and have greater control. A course of treatment that used to take a month can now be completed in a week.

Dr. Vigoda adds: "The system is so advanced that it can find even a tiny tumor and target it for radiation--even when it is close to a vital organ.” In the past,” he notes, “we often worried about harming organs that were very close to the tumors.”

Whereas previously a tumor close to the spine might have been both inoperable and beyond the possibility of irradiating, with the new accelerator, a Novalis Turebeam STx 2016, it’s much easier to pinpoint this lethal tumor and destroy it. If there are numerous metastases of brain cancer, they can be radiated simultaneously, decreasing the risk for the patient and providing more effective eradication of the cancer.

Among the system’s special features is a robotic couch, which the patients lies on during treatment.  It rotates in a variety of directions, allowing for maximum accuracy in positioning the patient for treatment. During the radiation therapy, the system checks the patient many times, photographing him so the physician can evaluate the accuracy of the therapy in real time. In addition, the system includes a mechanism that takes into account the patient’s breathing pattern and how it affects the patient’s positioning, ensuring maximum accuracy in targeting the tumor.

“This is one of the best accelerators in the world,” comments Prof. Tamar Peretz, head of the Sharett Institute. “Patients will surely enjoy better quality of life while undergoing treatment.”

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Monday, May 7 2018

Hadassah Cardiac Specialists Are Collaborating with Colleagues to Save Syrian Children

In an effort to save the lives of Syrian children suffering from life-threatening and complex heart abnormalities, the Hadassah Medical Organization and the Baruch Padeh Medical Center in Poriya-Tiberias have launched a unique collaboration as part of the Israel Defense Forces’ Good Neighbor program.

READ MORE ›
alt_text

Monday, May 7 2018

Pluristem Stem Cell Therapy, Based on Hadassah Preclinical Research, Has Been Cleared by FDA

Pluristem Therapeutics has announced that its new cell therapy to treat acute radiation syndrome (PLX-R18), based on the pioneering studies performed within the laboratory of Prof. Raphael Gorodetsky at the Hadassah Medical Organization, has received clearance from the United States Food and Drug Administration to treat individuals who may have been acutely exposed to high-dose radiation as the result of a nuclear attack or accident.

READ MORE ›
alt_text

Thursday, May 3 2018

HMO Exclusive Call with Nurse Rely Alon

Please join us for an exclusive conference call with Dr. Rely Alon, Director, Division of Nursing & Health Professions, Wednesday May 9, 2018 from 10:00 - 11:00 am EDT

READ MORE ›
alt_text

Tuesday, Apr 17 2018

Predicting Clinical Outcomes for Multiple Sclerosis Patients: Cutting-Edge Research at Hadassah

More than two million people--two to three times more women--have multiple sclerosis (MS)--the leading cause of neurological disability among young adults. What is their prognosis?

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More